http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20010217-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a22da5b7dd6ed60a21538e5edb23e051 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D253-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D253-075 |
| filingDate | 2000-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6740f9c1ff033e98f62cf6bdb292fd42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cd3a82c97519e7dd4352b27f6282d73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbea4632f6bb64c1395c460e41f77cbd |
| publicationDate | 2001-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | PE-20010217-A1 |
| titleOfInvention | URACILS SUBSTITUTED FOR ARYLS AND POLYCYCLIC HETEROARYLS USEFUL FOR THE SELECTIVE INHIBITION OF THE COAGULATION CASCADE |
| abstract | REFERS TO URACILS REPLACED WITH ARYLS AND POLYCYCLIC HETEROARYLS I, WHERE: B IS GROUP a; D1, D2, J1, J2, K1 ARE C, N, O, S, LINK, NO MORE THAN ONE OF D1, D2, J1, J2, K1 IS O, S, AMONG OTHER CONDITIONS; R9, R10, R11, R12, R13, R32, R33, R34, R35, R36 ARE HYDRIDE, ACETAMIDE, HALOACETAMIDE, AMONG OTHERS; R16, R19, R32, R33, R34, R35, R36 ARE Qb, NO MORE THAN ONE OF R16 AND R19 IS Qb; Qb IS Qbc; B IS HYDRIDE, TRIALKYLSILIL, C2-C8 ALKYL, AMONG OTHERS; A IS A LINK, (W7) rr- (CH (R15) pa Y (CH (R15)) pa- (W7) rr; rr ES 0-1; pa ES 0-6; W7 ES O, S, C ( O), (R7) NC (S), N (R7); R7 IS HYDRIDE, OH, ALKYL; R15 IS HYDRO, OH, IS NH, NOH; M IS N, R1-C; R1 IS HYDRIDE, ALKYL, ALKYL , AMONG OTHERS; R2 IS Z ° -Q; Z ° ES (CR41R42) q, q IS 1-3, AMONG OTHERS; W ° IS O, S, C (O), S (O), N (R41), AMONG OTHERS; R41 AND R42 ARE AMIDINE, HYDROXYAMINE, AMONG OTHERS; Q IS HYDRIDE; K IS (CR4aR4b) n, n IS 1-2; R4a AND R4b ARE HALO, HYDROXY, AMONG OTHERS; E ° IS E1 WHEN K IS ( CR4aR4b); E1 IS CO, C (S), CONR7, AMONG OTHERS; Y ° IS Qb-Qssss, AMONG OTHERS; Qssss ES (CH (R38)) r-W5; r ES 1-2; W5 ES 1.4 INDENYL; 1,5 INDENYL, AMONG OTHERS; R38 IS ARYL, HETEROARYL A PREFERRED COMPOUND 2- [3- [1- [3-AMINOPHENYL] -N - [[4-IMINOMETILPHENYL] METHYL] -5- [N, N -DIMETHYLHYDRAZINE] -2,4-DIOXO-2 (2H, 4H) -PYRIMIDINYL]] ACETAMIDE, AMONG OTHERS COMPOUND I INHIBITS THROMBOSIS, PLATELET FORMATION |
| priorityDate | 1999-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.